Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-28

Clinical Trial Update: Study on the Influence of Sunitinib and Sorafenib on Fatigue, QoL, Depression in Patients With Metastatic RCC or GIST

View source ↗

Summary

A completed clinical trial evaluated the impact of sunitinib and sorafenib on fatigue, quality of life, and depression in patients with metastatic renal cell ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nexavar (Sorafenib)
  • Sutent (sunitinib)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Renal Cell Cancer, Colorectal Cancer | Status: COMPLETED